Recently, SALL2 was found to be downregulated in several human cancer types, including breast cancer, ovarian cancer, and esophageal squamous cell carcinoma (Liu et al, 2007; Sung et al, 2013; Luo et al, 2017). Here, SALL2 is linked to cancer.